Productive partnership

Picking the right partners appears to have been a key ingredient that allowed biotherapeutics newcomer Samsung Group to go from zero to market in just five years.

The South Korean conglomerate first announced its intention to invest in biotherapeutics in March 2010, when it pledged to invest W2.1 trillion ($2 billion) over 10 years, with the expectation of W1.8 trillion in annual revenues by 2020...